223 related articles for article (PubMed ID: 7752651)
1. Effects of semotiadil fumarate (SD-3211) and its enantiomer, SD-3212, on the changes in cytosolic Ca2+ and tension caused by KCl and norepinephrine in isolated rat aortas.
Murakami K; Shindo K; Ito KM; Ito K
J Cardiovasc Pharmacol; 1995 Feb; 25(2):262-7. PubMed ID: 7752651
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of vascular relaxation by thaligrisine: functional and binding assays.
Tur R; Magraner J; Catret M; Elorriaga M; Ivorra MD; D'Ocon P; Bermejo A; Cabedo N; Cortes D; Anselmi E
Life Sci; 2000 Aug; 67(13):1535-48. PubMed ID: 10983849
[TBL] [Abstract][Full Text] [Related]
3. Calcium antagonistic and binding properties of semotiadil (SD-3211), a benzothiazine derivative assessed in cerebral and coronary arteries.
Nakayama K; Morimoto K; Nozawa Y; Tanaka Y
J Cardiovasc Pharmacol; 1992 Sep; 20(3):380-91. PubMed ID: 1279282
[TBL] [Abstract][Full Text] [Related]
4. Effects of a novel smooth muscle relaxant, KT-362, on contraction and cytosolic Ca2+ level in the rat aorta.
Sakata K; Karaki H
Br J Pharmacol; 1991 Jan; 102(1):174-8. PubMed ID: 1710524
[TBL] [Abstract][Full Text] [Related]
5. Cicletanine-induced decreases in cytosolic Ca2+ level and contraction in vascular smooth muscle.
Izumi M; Mitsui-Saito M; Ozaki H; Karaki H
Jpn J Pharmacol; 1998 Jan; 76(1):57-63. PubMed ID: 9517405
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of action of endothelin-1 as compared with other agonists in vascular smooth muscle.
Wallnöfer A; Weir S; Rüegg U; Cauvin C
J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S23-31; discussion S45. PubMed ID: 2473323
[TBL] [Abstract][Full Text] [Related]
7. Effects of semotiadil fumarate, a novel Ca2+ antagonist, on cytosolic Ca2+ level and force of contraction in porcine coronary arteries.
Kageyama M; Yanagisawa T; Taira N
Br J Pharmacol; 1995 Mar; 114(6):1289-95. PubMed ID: 7620720
[TBL] [Abstract][Full Text] [Related]
8. Effects of LP-805, a new vasodilating agent, on cytosolic Ca2+ and contraction in vascular smooth muscle of rat aorta.
Kishii K; Inazu M; Morimoto T; Tsujitani M; Takayanagi I
Gen Pharmacol; 1992 May; 23(3):355-63. PubMed ID: 1511847
[TBL] [Abstract][Full Text] [Related]
9. Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.
Flaim SF; Gleason MM; Hedberg A; Shank RP; McCullough JR; Gill A; Damiano BP; Brannan MD; Carson JR
J Pharmacol Exp Ther; 1991 Jan; 256(1):279-88. PubMed ID: 1846419
[TBL] [Abstract][Full Text] [Related]
10. HNS-32, a novel azulene-1-carboxamidine derivative, inhibits nifedipine-sensitive and -insensitive contraction of the isolated rabbit aorta.
Tanaka Y; Mitani A; Igarashi T; Someya S; Otsuka K; Imai T; Yamaki F; Tanaka H; Saitoh M; Nakazawa T; Noguchi K; Hashimoto K; Shigenobu K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):344-52. PubMed ID: 11284450
[TBL] [Abstract][Full Text] [Related]
11. Different effects of norepinephrine and KCl on the cytosolic Ca2+-tension relationship in vascular smooth muscle of rat aorta.
Karaki H; Sato K; Ozaki H
Eur J Pharmacol; 1988 Jul; 151(2):325-8. PubMed ID: 3169125
[TBL] [Abstract][Full Text] [Related]
12. Effects of felodipine, nifedipine and verapamil on cytosolic Ca2+ and contraction in vascular smooth muscle.
Hagiwara S; Mitsui M; Karaki H
Eur J Pharmacol; 1993 Mar; 234(1):1-7. PubMed ID: 7682512
[TBL] [Abstract][Full Text] [Related]
13. NO contributes to abnormal vascular calcium regulation and reactivity induced by peritonitis-associated septic shock in rats.
Chen SJ; Li SY; Shih CC; Liao MH; Wu CC
Shock; 2010 May; 33(5):473-8. PubMed ID: 19749606
[TBL] [Abstract][Full Text] [Related]
14. Investigations of the dual contractile/relaxant properties showed by antioquine in rat aorta.
Ivorra MD; Lugnier C; Catret M; Anselmi E; Cortes D; D'Ocon P
Br J Pharmacol; 1993 Jun; 109(2):502-9. PubMed ID: 8358549
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of vasoinhibitory effect of cardioprotective agent, CP-060S, in rat aorta.
Sato K; Satake N; Shibata S; Adachi Y; Karaki H
Eur J Pharmacol; 2000 Jul; 400(2-3):225-30. PubMed ID: 10988338
[TBL] [Abstract][Full Text] [Related]
16. L-type voltage-dependent Ca2+ and ATP-sensitive K+ channels are not involved in the regulation of bovine ciliary muscle contractility.
Kageyama M; Shirasawa E
J Ocul Pharmacol Ther; 1995; 11(4):553-63. PubMed ID: 8574819
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the effects of the calcium entry blockers, verapamil, diltiazem and flunarizine against contractions of the rat isolated aorta and portal vein.
Marriott JF
Br J Pharmacol; 1988 Sep; 95(1):145-54. PubMed ID: 3219471
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate (TMB-8) in vascular smooth muscle.
Ishihara H; Karaki H
Eur J Pharmacol; 1991 May; 197(2-3):181-6. PubMed ID: 1915568
[TBL] [Abstract][Full Text] [Related]
19. Calcium channel blocker-like action of 1,9-dideoxyforskolin in vascular smooth muscle.
Abe A; Karaki H
Jpn J Pharmacol; 1992 Dec; 60(4):389-92. PubMed ID: 1287276
[TBL] [Abstract][Full Text] [Related]
20. A novel benzothiazine Ca2+ channel antagonist, semotiadil, inhibits cardiac L-type Ca2+ currents.
Koidl B; Miyawaki N; Tritthart HA
Eur J Pharmacol; 1997 Mar; 322(2-3):243-7. PubMed ID: 9098694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
